MK-3281

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C29H37N3O3
Molecular Weight	475.6224
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN(C)CCN(C)[C@H]1COC2=CC=CC=C2C3=C(C4CCCCC4)C5=C(C=C(C=C5)C(O)=O)N3C1

InChI

InChIKey=YQUCBFIQSJVCOR-JOCHJYFZSA-N

InChI=1S/C29H37N3O3/c1-30(2)15-16-31(3)22-18-32-25-17-21(29(33)34)13-14-23(25)27(20-9-5-4-6-10-20)28(32)24-11-7-8-12-26(24)35-19-22/h7-8,11-14,17,20,22H,4-6,9-10,15-16,18-19H2,1-3H3,(H,33,34)/t22-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C29H37N3O3
Molecular Weight	475.6224
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21141896

MK-3281 is a potent and orally bioavailable inhibitor of HCV NS5B polymerase which combined excellent cell-based potency with good pharmacokinetic properties in preclinical species. MK-3281 was efficacious in the chimeric mouse model of HCV infection.

Approval Year

PubMed

Title	Date	PubMed
In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.	2013 Nov	24013001

Patents

Substance Class	Chemical Created by `admin` on `Tue Apr 01 16:25:49 GMT 2025` Edited by `admin` on `Tue Apr 01 16:25:49 GMT 2025`
Record UNII	3593C180JO
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MK 3281

Preferred Name

English

MK-3281

Common Name

English

6H-INDOLO(1,2-E)(1,5)BENZOXAZOCINE-11-CARBOXYLIC ACID, 14-CYCLOHEXYL-7-((2-(DIMETHYLAMINO)ETHYL)METHYLAMINO)-7,8-DIHYDRO-, (7R)-

Systematic Name

English

Code System Code Type Description

FDA UNII

3593C180JO